L’Oréal Active Cosmetics Division rebrands as L’Oréal Dermatological Beauty
The L’Oréal division formerly known as L’Oréal Active Cosmetics has been renamed L’Oréal Dermatological Beauty. The change was effective immediately, from the February 20 2023. It will be rolled out globally.
Home to pioneering dermatological brands, such as La Roche Posay, Vichy, CeraVe, SkinCeuticals and Decléor, the new identity is designed to better align the division with its objectives.
In the press statement announcing the news, L’Oréal reemphasised that purpose:
- A L’Oréal Division with complementary dermatological brands both on the pathological and aesthetic front.
- A Division with an inspiring mission: pioneer health and beauty to bring the world sustainable and life-changing dermatological solutions to all.
- A Division that accompanies healthcare professionals to change people’s lives and increase access to skin health, for everyone, everywhere.
As a division, the now-called L’Oréal Dermatological Beauty saw global sales rise by 30.6% to €5.125 billion (£4.4 billion) in 2022, as it posted double-digit growth in all regions. La Roche-Posay and CeraVe brands contributed to more than 80% of the divisional growth. It was suggested that this was due to increasing consumer needs and the role of dermatological skincare in meeting this demand.
In the statement, L’Oréal reiterated key statistics about the skincare industry, including that more than two billion people worldwide have skin issues today. It was proposed that this figure keeps growing as the population is ageing and individuals are increasingly exposed to urban pollution.
The company also noted a growing trend for consumers turning to medical professionals to meet their demanding aesthetic expectations. However, according to its in-house research, still, only 36%¹ of consumers have ever seen a healthcare professional about their skin in the UK.
This statistic, coupled with discussions around low access to the right education and resources, plus rife misinformation online, has led to concerns about consumers making decisions that could be harmful to their skin health.
Thus, L’Oréal sees the dermatological brands within the Dermatological Beauty division as having a critical role to play in addressing rising skin pathologies and aesthetic needs. That’s because they can offer skincare co-developed with doctors, as well as access to advice and dermatological services in this fast-evolving world.
“In the UK & Ireland we strive to democratise dermatology to provide equal access to all of the 42.7million² sufferers of skin concerns, by pioneering health and beauty to make life-changing and sustainable dermatological solutions accessible to all,” said the managing director of L’Oréal Dermatological Beauty UK & Ireland, Karen Flavard-Jones. “I’m so proud of our new name, which is not only a clear expression of who we are and what we stand for, but aligned to the dermatological beauty category consumers shop from, bringing together brands not only highly recommended by dermatologists, but prescribed by doctors in their surgeries.”
¹Kantar Omnibus, L’Oreal Consumer Insights